Counterpoint Mutual Funds’s Genesco GCO Stock Holding History

Counterpoint Mutual Funds’s Portfolio GCO Stock Details GCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-987	Closed	-$63K	–	280
2022 Q1	$63K	Buy	+987	New	+$64.2K	0.05%	147

Other funds holding GCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Counterpoint Mutual Funds's GCO Position: Q2 2022 in Review

Counterpoint Mutual Funds sold out of Genesco (GCO) in Q2 2022, closing a stake of 987 shares — an estimated $63K sold.

Counterpoint Mutual Funds first reported a position in GCO in Q1 2022 and held it in 1 quarter. The position peaked at $63K in Q1 2022. 168 funds tracked by Wall St. Rank hold GCO as of Q2 2022.

Counterpoint Mutual Funds reported no remaining Genesco position as of Q2 2022 after selling out during the quarter.
Counterpoint Mutual Funds sold 987 Genesco shares in Q2 2022, an estimated $63K.
Counterpoint Mutual Funds first reported a position in Genesco in Q1 2022 and held it in 1 quarter.
Counterpoint Mutual Funds's Genesco position peaked at $63K in Q1 2022.
168 funds tracked by Wall St. Rank held Genesco as of Q2 2022.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2022, filed 28 Jul 2022.